Lupus Research Alliance: Novel Research Grants and Target Identification Programme

Award Title: Novel Research Grants and Target Identification Programme

CALHN Internal Closing Date: 25 January 2019

The Lupus Research Alliance invites applications the following schemes.

Novel Research Grant Program
This program provides early stage support for high-risk, high-reward, idea-driven investigations into the fundamental mechanisms of lupus and its complications, and the explorations of novel targets, pathways and technologies. The aim is to stimulate the study of underexplored avenues that can lead to the development of safer and more effective treatments. Special emphasis is placed on lupus studies exploring fundamental mechanisms, novel targets and pathways, novel technologies and interdisciplinary approaches.

  • Funding & Duration: Grants are worth up to USD $150,000 (approx. AUD $208,000) per year, for up to three years.
  • Eligibility: Individuals with a doctoral degree, MD, PhD, DO or equivalent, holding a faculty, or equivalent, position at the instructor level and above at an academic or research institution may apply. There are no citizenship requirements. US federal government research laboratories are not eligible

Target Identification in Lupus Programme
This supports research highly focused on lupus that should lead directly to knowledge that will facilitate drug discovery or testing of new treatments. These therapies may be used to treat systemic or organ-specific manifestations of lupus, although they may find applicability in the setting of other autoimmune or inflammatory illnesses. Research must be based on realisable goals for translation into therapeutic discovery programmes. Targets can include small molecules, biologic agents, vaccines, gene therapy, as well as novel approaches in public health and risk reduction.

  • Funding & Duration: Grants are worth up to USD $200,000 (approx. AUD $277,000) per year for up to three years.
  • Eligibility: Individuals with a doctoral degree such as MD, PhD or DO, holding a faculty, or equivalent, position at the instructor level and above at an academic or research institution are eligible to apply. There are no citizenship requirements. Research in industry or collaborations between academia and industry are supported.

SUBMISSION TO THE SPONSOR DUE DATE 01 FEBRUARY 2019

CALHN SUBMISSION REQUIREMENTS

TQEH Research staff (Clinical and Affiliate Title Holders) affiliated with the University of Adelaide, and Non-affiliated staff  Please co-ordinate your application through TQEH Research Secretariat.
Contact: Gwenda Graves phone: 8222 6870 gwenda.graves@sa.gov.au

RAH and SA PATHOLOGY Research staff (Clinical and Affiliate Title Holders) affiliated with the University of Adelaide, and Non-affiliated staff  Please co-ordinate your application through CALHN  Research Office.
Contact:  7117 2217  Health.CALHNResearchGrants@sa.gov.au

SUBMISSION BY UNIVERSITY OF ADELAIDE RESEARCHERS

  • Applications must be submitted for internal review by 25 January 2019
  • Please email rbinternational@adelaide.edu.au if you are considering applying for this scheme.

Submit an Application to Research Services for Review

SUBMISSION BY UNIVERSITY OF SOUTH AUSTRALIA RESEARCHERS
For submission details please contact:
Research and Innovation Services
University of South Australia
Mawson Lakes Campus
Phone: 8302 3247

All UniSA applications require a completed and signed hard copy of the Grant Application Coversheet to accompany the application.
Refer to the UniSA funding calendar here.

For further information and application instructions please visit: 

https://www.lupusresearch.org/research-and-clinical-trials/research/funding-opportunities/

Return to Grants - International